Shashi Kant

University Of Texas Hlth Ctr At Tyler

$3,111,895

Attributed

$3,111,895

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $576.7K · FY2019–25

$1M$750K$500K$250K$0

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$3,111,895 · 3

By mechanism

R01$2,699,033 · 2

R21$412,862 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Emerging Leaders on “Safety”

Beth Baseler · Leidos Biomedical Research, Inc.$225,257,316
Kimberly Smith · Ppd Development Lp$122,008,792
Klaus Romero · Critical Path Institute$90,404,592
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$75,904,237
Yunda Huang · Fred Hutchinson Cancer Center$70,809,823
Leonard Freedman · Leidos Biomedical Research, Inc.$64,938,611

Research focus

SafetyFiberPharmaceutical PreparationsRegimenTherapy DurationTreatment ProtocolsMycobacterium TuberculosisOptimal TreatmentsEthambutolPharmacodynamicsSimulationSynergismTranslatingToxic EffectClinical TrialsDoseDesignBacteriaDrug ResistanceDrug CombinationsDrug KineticsDrug ExposureIn SilicoIsoniazid